Serum autoantibodies to oligodendrocyte and neuronal cell surface antigens in multiple sclerosis patients

Serum autoantibodies to oligodendrocyte and neuronal cell surface antigens in multiple sclerosis patients

Detalles Bibliográficos
Main Authors:	Lily, O, Palace, J, Vincent, A
Formato:	Journal article
Publicado:	2002

Títulos similares

Serum autoantibodies against intracellular antigens in multiple sclerosis
por: Lily, O, et al.
Publicado: (2002)

Serum autoantibodies to cell surface determinants in multiple sclerosis: a flow cytometric study.
por: Lily, O, et al.
Publicado: (2004)

Serum Anti-oligodendrocyte Autoantibodies in Patients With Multiple Sclerosis Detected by a Tissue-Based Immunofluorescence Assay
por: Yukino Miyachi, et al.
Publicado: (2021-08-01)

Pathogenic autoantibodies to neuronal proteins in neurological disorders.
por: Vincent, A, et al.
Publicado: (1999)

An approach to the identification of targets of autoantibodies in multiple sclerosis
por: Littleton, E, et al.
Publicado: (2004)

Immunocapture and identification of cell membrane protein antigenic targets of serum autoantibodies.
por: Littleton, E, et al.
Publicado: (2009)

3285 Toxicity of Released B Cell Products in Multiple Sclerosis: Effects on Neurons and Oligodendrocytes
por: Leah Zuroff, et al.
Publicado: (2019-03-01)

Oligodendrocyte Injury in Multiple Sclerosis.
por: Mateo Përgjegji, et al.
Publicado: (2025-01-01)

Towards defining antigenic targets for antibodies in multiple sclerosis
por: Littleton, E, et al.
Publicado: (2006)

Autoantibodies to neuronal surface antigens in thyroid antibody-positive and -negative limbic encephalitis.
por: Tüzün, E, et al.
Publicado: (2011)

Autoantigens and Autoantibodies in Multiple Sclerosis
por: Abbas Mirshafiey, et al.
Publicado: (2013-12-01)

Oligodendrocyte Development and Regenerative Therapeutics in Multiple Sclerosis
por: Nadjet Gacem, et al.
Publicado: (2021-04-01)

Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis
por: Jurynczyk, M, et al.
Publicado: (2017)

MicroRNAs dysregulated in multiple sclerosis affect the differentiation of CG-4 cells, an oligodendrocyte progenitor cell line
por: Océane Perdaens, et al.
Publicado: (2024-02-01)

The contribution of oligodendrocytes and oligodendrocyte progenitor cells to central nervous system repair in multiple sclerosis: perspectives for remyelination therapeutic strategies
por: Adriana Octaviana Dulamea
Publicado: (2017-01-01)

Grey matter neuronal loss in multiple sclerosis
por: Cifelli, A, et al.
Publicado: (2002)

Age influenced cattle serum antigen detected by autoantibodies
por: Bettini TM, et al.
Publicado: (1974-10-01)

Inflammatory microglia correlate with impaired oligodendrocyte maturation in multiple sclerosis
por: J. Q. Alida Chen, et al.
Publicado: (2025-01-01)

Neocortical neuronal, synaptic, and glial loss in multiple sclerosis.
por: Wegner, C, et al.
Publicado: (2006)

Connecting Neuroinflammation and Neurodegeneration in Multiple Sclerosis: Are Oligodendrocyte Precursor Cells a Nexus of Disease?
por: Morgan W. Psenicka, et al.
Publicado: (2021-06-01)

A Minimally-invasive Blood-derived Biomarker of Oligodendrocyte Cell-loss in Multiple Sclerosis
por: John A. Olsen, et al.
Publicado: (2016-08-01)

Efficient Generation of Myelinating Oligodendrocytes from Primary Progressive Multiple Sclerosis Patients by Induced Pluripotent Stem Cells
por: Panagiotis Douvaras, et al.
Publicado: (2014-08-01)

Semaphorin4A Is Cytotoxic to Oligodendrocytes and Is Elevated in Microglia and Multiple Sclerosis
por: Dominique F. Leitner, et al.
Publicado: (2015-05-01)

Mechanisms Governing Oligodendrocyte Viability in Multiple Sclerosis and Its Animal Models
por: Zhixin Lei, et al.
Publicado: (2024-01-01)

Autoantibody and Viral Serologic Examinations in Multiple Sclerosis and Stroke
por: Beuy Joob, et al.
Publicado: (2020-12-01)

Autoantibodies and Sjogren's Syndrome in multiple sclerosis, a reappraisal.
por: Andrew J Solomon, et al.
Publicado: (2013-01-01)

Flow cytometry as a new method for the detection of surface antigens/surface-binding autoantibodies
por: Blaes, F, et al.
Publicado: (2000)

Novel neuronal surface autoantibodies in plasma of patients with depression and anxiety
por: Shenghua Zong, et al.
Publicado: (2020-11-01)

Anti-Neuronal Autoantibodies (Cell Surface and Onconeural) and Their Association With Natural Autoantibodies in Synthetic Cannabinoid-Induced Psychosis
por: Lídia Hau, et al.
Publicado: (2022-05-01)

Complement-dependent cytotoxicity of human autoantibodies against myelin oligodendrocyte glycoprotein
por: Kuniko Kohyama, et al.
Publicado: (2023-02-01)

The association of multiple sclerosis with bullous pemphigoid: is there a shared antigen response?
por: Taghipour, K, et al.
Publicado: (2012)

Bioenergetic Failure in Rat Oligodendrocyte Progenitor Cells Treated with Cerebrospinal Fluid Derived from Multiple Sclerosis Patients
por: Deepali Mathur, et al.
Publicado: (2017-07-01)

Profile of autoantibodies in systemic sclerosis
por: M. N. Starovoitova, et al.
Publicado: (2016-10-01)

Cerebral organoids in primary progressive multiple sclerosis reveal stem cell and oligodendrocyte differentiation defect
por: Nicolas Daviaud, et al.
Publicado: (2023-03-01)

Mechanisms of metabolic stress induced cell death of human oligodendrocytes: relevance for progressive multiple sclerosis
por: Milton Guilherme Forestieri Fernandes, et al.
Publicado: (2023-07-01)

Screening for pathogenic neuronal autoantibodies in serum and CSF of patients with first-episode psychosis
por: Theorell, J, et al.
Publicado: (2021)

Screening for pathogenic neuronal autoantibodies in serum and CSF of patients with first-episode psychosis
por: Jakob Theorell, et al.
Publicado: (2021-11-01)

Multiple system atrophy: α-Synuclein strains at the neuron-oligodendrocyte crossroad
por: Kreesan Reddy, et al.
Publicado: (2022-11-01)

The evaluation of a novel "goat serum" therapy (Aimspro) in multiple sclerosis
por: Burke, G, et al.
Publicado: (2005)

Antigen-bound and free β-amyloid autoantibodies in serum of healthy adults.
por: Madalina Maftei, et al.
Publicado: (2012-01-01)